Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. 10x Genomics Inc shares valued at $225,852 were sold by Taich Adam on Nov 24 ’25. At $19.00 per share, Taich Adam sold 11,888 shares. The insider’s holdings dropped to 297,385 shares worth approximately $5.4 million following the completion of this transaction.
Also, Hindson Benjamin J. sold 8,283 shares, netting a total of over 157,363 in proceeds. Following the sale of shares at $19.00 each, the insider now holds 432,605 shares.
Before that, Saxonov Serge had sold 13,261 shares from its account. In a trade valued at $251,936, the Chief Executive Officer traded 10x Genomics Inc shares for $19.00 each. Upon closing the transaction, the insider’s holdings decreased to 13,261 shares, worth approximately $18.54 million.
As published in a research note from Morgan Stanley on December 02, 2025, 10x Genomics Inc [TXG] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $20. Analysts at Piper Sandler started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid September. As of February 13, 2025, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for TXG. Earlier on September 03, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for TXG stock.
Analyzing TXG Stock Performance
On last trading session, 10x Genomics Inc [NASDAQ: TXG] rose 1.57% to $18.15. The stock’s lowest price that day was $17.06, but it reached a high of $18.305 in the same session. During the last five days, there has been a drop of approximately -3.20%. Over the course of the year, 10x Genomics Inc shares have jumped approximately 10.20%. Shares of the company reached a 52-week high of $20.34 on 11/25/25 and a 52-week low of $6.78 on 04/07/25.
Support And Resistance Levels for 10x Genomics Inc (TXG)
According to the 24-hour chart, there is a support level at 17.37, which, if violated, would cause prices to drop to 16.59. In the upper region, resistance lies at 18.62. The next price resistance is at 19.08. RSI (Relative Strength Index) is 61.59 on the 14-day chart, showing neutral technical sentiment.
Is 10x Genomics Inc subject to short interest?
Stocks of 10x Genomics Inc saw a sharp rise in short interest on 2025-11-14 jumping by 2.96 million shares to 15.5 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 12.55 million shares. A jump of 19.06% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.98.
Which companies own the most shares of 10x Genomics Inc (TXG)?
In terms of 10x Genomics Inc share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, down nearly -16.06% from the previous closing price of $17.87. Analysts anticipate 10x Genomics Inc stock to reach 20 by 2025, with the lowest price target being 13. In spite of this, 8 analysts ranked 10x Genomics Inc stock as Hold at the end of 2025. On July 22, 2024, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $24.
